GSK boosts plant job cuts by 20

GlaxoSmithKline has tagged as redundant another 20 positions at its Ulverston, UK, manufacturing plant. The cuts were scheduled to be made Monday.

The plant has been under renovation at the same time the staff cuts were announced. The 2008 plan calls for an existing staff of 540 to be cut to less than 250. To make the cuts possible, GSK planned to outsource some intermediates manufacturing and update the plant and equipment. Ulverston was to retain its "specialist sterile manufacture and oral spraying technologies," according to a UK press report.

The number of cuts would have been higher. But some have been forestalled by production issues stemming from bad winter weather and a delayed product development contract.

- here's the article

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.